发明名称 HCV IMMUNOTHERAPY.
摘要 <p>The invention relates to the use of lnterleukin-7 (IL-7), for treating hepatitis C in a patient infected with hepatitis C virus, wherein said patient has been treated or is being treated with an antiviral agent or a combination of antiviral agents that reduces viral load.</p>
申请公布号 MX2014001355(A) 申请公布日期 2014.11.21
申请号 MX20140001355 申请日期 2012.08.02
申请人 CYTHERIS 发明人 MICHEL MORRE;BRIGITTE SOULINE;THÉRÈSE CROUGHS;PIERRE DEMOL;STHEPANIE BEQ
分类号 A61K38/20;A61P1/16;A61P31/12 主分类号 A61K38/20
代理机构 代理人
主权项
地址